| 000 | 01698cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030247.0 | ||
| 008 | 100808s2009 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.12.21.M.Sc.2009.Ma.E | ||
| 100 | 0 | _aMarwa Tantawy Ali Mohamed | |
| 245 | 1 | 0 |
_aExpression of Bc1- 2 in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia AML / _cMarwa Tantawy Ali Mohamed ; Supervised Ahmed Mohamed Osman , Nahed Abdelwahab , Jehan Abdelbaset |
| 246 | 1 | 5 | _aظهور Be1- 2 فى حالات سرطان الدم الليمفاوى الحاد وسرطان الدم الميلودى الحاد |
| 260 |
_aCairo : _bMarwa Tantawy Ali Mohamed , _c2009 |
||
| 300 |
_a131P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Science - Department of Zoology | ||
| 520 | _aThe defects in mitochondrial - mediated pathway of apoptosis may lead to over expression of certain genes such as Bc1- 2 which plays a critical role in inhibiting anticancer drug - induced apoptosis . So high levels of Bc1- 2 expression have generally been shown to correlate with a poor treatment outcome in some hematological malignancies | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcute lymphoblastic leukemia | |
| 653 | 4 | _aAcute myeloid leukemia | |
| 653 | 4 | _aBc1-2 | |
| 700 | 0 |
_aAhmed Mohamed Osman , _eSupervisor |
|
| 700 | 0 |
_aJehan Abdelbaset , _eSupervisor |
|
| 700 | 0 |
_aNahed Abdelwahab , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c31008 _d31008 |
||